SAMIR HADDAD, MD
NPI 1841248234, individual, Denver, CO, Psychiatry & Neurology, Neurology
- Listed on the NY Medicaid exclusion list since March 15, 2010.
- Medicaid still paid claims in 8 later months, $6,619 in total.
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| NY Medicaid exclusion list ny omig medicaid exclusion list (tab-delimited, sept 2026) | Exact NPI, name verified | Mar 15, 2010 | still open | 8 | Oct 2021 | Nov 2023 | $7K | $0 |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | SAMIR HADDAD, MD |
| Type | Individual, sole proprietor |
| Status | Active |
| NPI issued | May 5, 2006, last updated October 30, 2025 |
| Practice location | 4700 E ILIFF AVE, Denver, CO 80222-6025, 303-335-0062 |
| Specialties | Psychiatry & Neurology, Neurology (2084N0400X, primary, license DR0071392 CO) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| 0031A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage; single dose | $5K | 76% | $39 | $36 (top 5% from $53) | too few months to rank | |
| 0071A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 10 mcg/0.2ml dosage, diluent reconstituted, tris-sucrose formulation; first dose | $720 | 11% | $40 | $40 (top 5% from $76) | too few months to rank | |
| 0001A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | $480 | 7% | $40 | $36 (top 5% from $65) | too few months to rank | |
| 0072A | Medicaid service code | $280 | 4% | $20 | $40 (top 5% from $80) | too few months to rank | |
| 99202 | New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more | $117 | 2% | $0.79 | $45 (top 5% from $138) | too few months to rank | |
| 91303 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, for intramuscular use | $0 | 0% | $0.00 | $0.00 (top 5% from $0.21) | too few months to rank | |
| 91305 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, tris-sucrose formulation, for intramuscular use | $0 | 0% | $0.00 | $0.00 (top 5% from $0.07) | too few months to rank | |
| 93890 | Ultrasound of within the brain blood flow following medication | $0 | 0% | $0.00 | $102 (top 5% from $232) | too few months to rank |
| code | what it is | services | beneficiaries | paid | submitted per service | allowed per service | charge to allowed | usual for this code |
|---|---|---|---|---|---|---|---|---|
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | 150 | 150 | $48K | $450 | $406 | 1.1x | 3.0x (90th percentile 8.4x) |
| 93890 | Ultrasound of within the brain blood flow following medication | 223 | 223 | $40K | $320 | $232 | 1.4x | 2.0x (90th percentile 3.6x) |
| 93886 | Complete ultrasound of within the brain blood flow | 220 | 220 | $38K | $420 | $224 | 1.9x | 2.1x (90th percentile 5.0x) |
| 93892 | Ultrasound of within the brain blood flow for blood clots | 220 | 220 | $29K | $300 | $168 | 1.8x | 3.2x (90th percentile 6.1x) |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 141 | 96 | $10K | $120 | $91 | 1.3x | 2.2x (90th percentile 3.8x) |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | 31 | 31 | $7K | $310 | $273 | 1.1x | 4.2x (90th percentile 9.5x) |
| 92546 | Test for abnormal eye movement using a rotating chair | 53 | 53 | $6K | $155 | $137 | 1.1x | 2.0x (90th percentile 3.9x) |
| 93880 | Ultrasound of both sides of head and neck blood flow | 31 | 31 | $5K | $300 | $196 | 1.5x | 3.3x (90th percentile 8.0x) |
A submitted charge many times the allowed amount is common and lawful; it matters when it is far above what other providers submit for the same code.
In this area
37 providers in Denver County, CO carry an indicator in the public record, with $31.3M at stake between them. The most common is more hours than a day holds, on 21 of them, followed by part of a provider network on 15. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | NEW GENESIS LLC Denver, CO, ranked 153 | $90K |
|
| 3 | MGA HOME HEALTHCARE COLORADO, LLC Glendale, CO, ranked 1396 | $66K |
|
| 3 | GREATER DENVER HOME HEALTH CARE INC Denver, CO, ranked 1711 | $0 |
|
| 3 | FIRST COLORADO HOME HEALTH CARE INC Denver, CO, ranked 2046 | $0 |
|
| 3 | CENTER AT LOWRY, LLC Denver, CO, ranked 2093 | $0 |
|
| 3 | AURORA PALLIATIVE AND HOSPICE CARE INC Denver, CO, ranked 2099 | $0 |
|
| 3 | OPTIMAL HOME CARE INC. Denver, CO, ranked 2214 | $0 |
|
| 3 | MED CARE HOSPICE INC Denver, CO, ranked 2564 | $0 |
|
Recent enforcement in CO
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.